Phototherapy in psoriasis: A review of mechanisms of action

Journal of Cutaneous Medicine and Surgery

Volumn 17, Issue 1, 2013, Pages 6-12

  Wong, Tami ^a   Hsu, Leon ^a   Liao, Wilson ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; DOUBLE STRANDED DNA; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 2; INTERLEUKIN 20; INTERLEUKIN 22; INTERLEUKIN 23; INTERLEUKIN 4; INTERLEUKIN 5; MESSENGER RNA; PSORALEN; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN BINDING PROTEIN 7; UNCLASSIFIED DRUG;

APOPTOSIS; CONTACT ALLERGY; CYTOKINE RESPONSE; DNA FRAGMENTATION; GENE; GENE EXPRESSION REGULATION; HUMAN; IGFBP7 GENE; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; LANGERHANS CELL; NONHUMAN; PHOTOTHERAPY; PRIORITY JOURNAL; PSORIASIS; RADIATION INJURY; REVIEW; SUN EXPOSURE; TH1 CELL; TH17 CELL; TH2 CELL; TREATMENT OUTCOME; ULTRAVIOLET A RADIATION; ULTRAVIOLET B RADIATION;

APOPTOSIS; CYTOKINES; DOWN-REGULATION; HUMANS; IMMUNOSUPPRESSION; KERATINOCYTES; PHOTOTHERAPY; PSORIASIS; T-LYMPHOCYTES;

EID: 84875433042     PISSN: 12034754     EISSN: None     Source Type: Journal    
DOI: 10.2310/7750.2012.11124     Document Type: Review

References (59)

1. McDonagh AF. Phototherapy: from ancient Egypt to the new millennium. J Perinatol 2001;21 Suppl 1:S7-12, doi:10.1038/sj.jp. 7210625.
2. Perry HO, Soderstrom CW, Schulze RW. The Goeckerman treatment of psoriasis. Arch Dermatol 1968;98:178-82, doi: 10.1001/archderm.1968. 01610140076019.
3. Ingram JT. The approach to psoriasis. Br Med J 1953;2:591-4, doi:10.1136/bmj.2.4836.591.
4. Parrish JA, Jaenicke KF. Action spectrum for phototherapy of psoriasis. J Invest Dermatol 1981;76:359-62, doi:10.1111/1523-1747.ep12520022.
5. Melski JW, Tanenbaum L, Parrish JA, et al. Oral methoxsalen photochemotherapy for the treatment of psoriasis: a cooperative clinical trial. J Invest Dermatol 1977;68:328-35, doi:10.1111/1523-1747.ep12496022.
6. Wolff KW, Fitzpatrick TB, Parrish JA, et al. Photochemotherapy for psoriasis with orally administered methoxsalen. Arch Dermatol 1976;112:943-50, doi:10.1001/archderm.1976.01630310005001.
7. Walter JF, Voorhees JJ. Psoriasis improved by psoralen plus black light. Acta Derm Venereol 1973;53:469-72.
8. Fischer T, Alsins J. Treatment of psoriasis with trioxsalen baths and dysprosium lamps. Acta Derm Venereol 1976;56:383-90.
9. Duarte I, Cunha JA, Bedrikow RB, Lazzarini R. What is the most common phototherapy prescription for psoriasis: NB-UVB or PUVA? Prescription behavior. An Bras Dermatol 2009;84:244-8, doi:10.1590/S0365-05962009000300005.
10. Koo JY. Current consensus and update on psoriasis therapy: a perspective from the U.S. J Dermatol 1999;26:723-33.
11. Lapolla W, Yentzer BA, Bagel J, et al. A review of phototherapy protocols for psoriasis treatment. J Am Acad Dermatol 2011;64: 936-49, doi:10.1016/j.jaad.2009.12.054.
12. Schlaak JF, Buslau M, Jochum W, et al. T cells involved in psoriasis vulgaris belong to the Th1 subset. J Invest Dermatol 1994;102:145-9, doi:10.1111/1523-1747.ep12371752.
13. Uyemura K, Yamamura M, Fivenson DF, et al. The cytokine network in lesional and lesion-free psoriatic skin is characterized by a T-helper type 1 cell-mediated response. J Invest Dermatol 1993;101:701-5, doi:10.1111/1523-1747. ep12371679.
14. Enk CD, Sredni D, Blauvelt A, Katz SI. Induction of IL-10 gene expression in human keratinocytes by UVB exposure in vivo and in vitro. J Immunol 1995;154:4851-6.
15. Barr RM, Walker SL, Tsang W, et al. Suppressed alloantigen presentation, increased TNF-alpha, IL-1, IL-1Ra, IL-10, and modulation of TNF-R in UV-irradiated human skin. J Invest Dermatol 1999;112:692-8, doi:10.1046/j.1523- 1747.1999.00570.x.
16. Skov L, Hansen H, Allen M, et al. Contrasting effects of ultraviolet A1 and ultraviolet B exposure on the induction of tumour necrosis factor-alpha in human skin. Br J Dermatol 1998;138:216-20, doi:10.1046/j.1365-2133.1998.02063.x.
17. Asadullah K, Sterry W, Stephanek K, et al. IL-10 is a key cytokine in psoriasis. Proof of principle by IL-10 therapy: a new therapeutic approach. J Clin Invest 1998;101:783-94, doi:10.1172/JCI1476.
18. Soyland E, Heier I, Rodriguez-Gallego C, et al. Sun exposure induces rapid immunological changes in skin and peripheral blood in patients with psoriasis. Br J Dermatol 2011;164:344-55, doi:10.1111/j.1365-2133.2010.10149.x.
19. Sigmundsdottir H, Johnston A, Gudjonsson JE, Valdimarsson H. Narrowband-UVB irradiation decreases the production of proinflammatory cytokines by stimulated T cells. Arch Dermatol Res 2005;297:39-42, doi:10.1007/s00403- 005-0565-9.
20. Johnson-Huang LM, Suárez-Farinas M, Sullivan-Whalen M, et al. Effective narrow-band UVB radiation therapy suppresses the IL-23/IL-17 axis in normalized psoriasis plaques. J Invest Dermatol 2010;130:2654-63, doi:10.1038/jid.2010.166.
21. Piskin G, Tursen U, Sylva-Steenland RM, et al. Clinical improvement in chronic plaque-type psoriasis lesions after narrow-band UVB therapy is accompanied by a decrease in the expression of IFN-gamma inducers-IL-12, IL-18 and IL-23. Exp Dermatol 2004;13:764-72, doi:10.1111/j.0906-6705.2004.00246.x.
22. Walters IB, Ozawa M, Cardinale I, et al. Narrowband (312-nm) UV-B suppresses interferon gamma and interleukin (IL) 12 and increases IL-4 transcripts: differential regulation of cytokines at the single-cell level. Arch Dermatol 2003;139:155-61, doi:10.1001/archderm.139.2.155.
23. Racz E, Prens EP, Kurek D, et al. Effective treatment of psoriasis with narrow-band UVB phototherapy is linked to suppression of the IFN and Th17 pathways. J Invest Dermatol 2011;131:1547-58, doi:10.1038/jid.2011.53.
24. Ravic-Nikolic A, Radosavljevic G, Jovanovic I, et al. Systemic photochemotherapy decreases the expression of IFN-gamma, IL-12p40 and IL-23p19 in psoriatic plaques. Eur J Dermatol 2011;21: 53-7.
25. Singh TP, Schon MP, Wallbrecht K, et al. 8-Methoxypsoralen plus ultraviolet A therapy acts via inhibition of the IL-23/Th17 axis and induction of Foxp3+ regulatory T cells involving CTLA4 signaling in a psoriasis-like skin disorder. J Immunol 2010;184:7257-67, doi:10.4049/jimmunol.0903719.
26. Coimbra S, Oliveira H, Reis F, et al. Interleukin (IL)-22, IL-17, IL-23, IL-8, vascular endothelial growth factor and tumour necrosis factor-alpha levels in patients with psoriasis before, during and after psoralen-ultraviolet A and narrowband ultraviolet B therapy. Br J Dermatol 2010;163:1282-90, doi:10.1111/j.1365-2133.2010.09992.x.
27. Rotsztejn H, Zalewska A, Trznadel-Budzko E, et al. Influence of systemic photochemotherapy on regulatory T cells and selected cytokine production in psoriatic patients: a pilot study. Med Sci Monit 2005;11:CR594-8.
28. Lippens S, Hoste E, Vandenabeele P, et al. Cell death in the skin. Apoptosis 2009;14:549-69, doi:10.1007/s10495-009-0324-z.
29. Krueger JG, Wolfe JT, Nabeya RT, et al. Successful ultraviolet B treatment of psoriasis is accompanied by a reversal of keratinocyte pathology and by selective depletion of intraepidermal T cells. J Exp Med 1995;182:2057-68, doi:10.1084/jem.182.6.2057.
30. Ozawa M, Ferenczi K, Kikuchi T, et al. 312-Nanometer ultraviolet B light (narrow-band UVB) induces apoptosis of T cells within psoriatic lesions. J Exp Med 1999;189:711-8, doi:10.1084/jem.189.4.711.
31. Ceović R, Pasić A, Lipozencić J, et al. Antiproliferative, antiangiogenic and apoptotic effect of photochemotherapy (PUVA) in psoriasis patients. Coll Antropol 2007;31:551-6.
32. DeSilva B, McKenzie RC, Hunter JA, Norval M. Local effects of TL01 phototherapy in psoriasis. Photodermatol Photoimmunol Photomed 2008;24:268-9, doi:10.1111/j.1600-0781.2008.00366.x.
33. Weatherhead SC, Farr PM, Jamieson D, et al. Keratinocyte apoptosis in epidermal remodeling and clearance of psoriasis induced by UV radiation. J Invest Dermatol 2011;131:1916-26, doi:10.1038/jid.2011.134.
34. Kolgen W, Both H, van Weelden H, et al. Epidermal Langerhans cell depletion after artificial ultraviolet B irradiation of human skin in vivo: apoptosis versus migration. J Invest Dermatol 2002;118: 812-7, doi:10.1046/j.1523-1747.2002.01742.x.
35. Kulms D, Poppelmann B, Yarosh D, et al. Nuclear and cell membrane effects contribute independently to the induction of apoptosis in human cells exposed to UVB radiation. Proc Natl Acad Sci U S A 1999;96:7974-9, doi:10.1073/pnas.96. 14.7974.
36. Rosette C, Karin M. Ultraviolet light and osmotic stress: activation of the JNK cascade through multiple growth factor and cytokine receptors. Science 1996;274:1194-7, doi:10.1126/science.274.5290. 1194.
37. Aragane Y, Kulms D, Metze D, et al. Ultraviolet light induces apoptosis via direct activation of CD95 (Fas/APO-1) independently of its ligand CD95L. J Cell Biol 1998;140:171-82, doi:10.1083/jcb.140.1.171.
38. Godar DE. UVA1 radiation triggers two different final apoptotic pathways. J Invest Dermatol 1999;112:3-12, doi:10.1046/j.1523-1747.1999.00474.x.
39. Kulms D, Zeise E, Poppelmann B, Schwarz T. DNA damage, death receptor activation and reactive oxygen species contribute to ultraviolet radiation-induced apoptosis in an essential and independent way. Oncogene 2002;21:5844-51, doi:10.1038/sj.onc. 1205743.
40. Morita A, Werfel T, Stege H, et al. Evidence that singlet oxygeninduced human T helper cell apoptosis is the basic mechanism of ultraviolet-A radiation phototherapy. J Exp Med 1997;186:1763-8, doi:10.1084/jem.186.10.1763.
41. Leverkus M, Yaar M, Gilchrest BA. Fas/Fas ligand interaction contributes to UV-induced apoptosis in human keratinocytes. Exp Cell Res 1997;232:255-62, doi:10.1006/excr.1997.3514.
42. Gutierrez-Steil C, Wrone-Smith T, Sun X, et al. Sunlight-induced basal cell carcinoma tumor cells and ultraviolet-B-irradiated psoriatic plaques express Fas ligand (CD95L). J Clin Invest 1998; 101:33-9, doi:10.1172/JCI1165.
43. Seite S, Zucchi H, Moyal D, et al. Alterations in human epidermal Langerhans cells by ultraviolet radiation: quantitative and morphological study. Br J Dermatol 2003;148:291-9, doi:10.1046/j.1365-2133.2003.05112.x.
44. McLoone P,WoodsGM, NorvalM. Decrease inLangerhans cells and increase in lymph node dendritic cells following chronic exposure of mice to suberythemal doses of solar simulated radiation. Photochem Photobiol 2005;81:1168-73, doi:10.1562/2005-04-10-RA-484.
45. Weiss JM, Renkl AC, Denfeld RW, et al. Low-dose UVB radiation perturbs the functional expression of B7.1 and B7.2 co-stimulatory molecules on human Langerhans cells. Eur J Immunol 1995;25: 2858-62, doi:10.1002/eji.1830251022.
46. Danno K, Toda K, Horio T. The effect of 8-methoxypsoralen plus long-wave ultraviolet (PUVA) radiation on mast cells: PUVA suppresses degranulation of mouse skin mast cells induced by compound 48/80 or concanavalin A. J Invest Dermatol 1985;85: 110-4, doi:10.1111/1523-1747.ep12276497.
47. Danno K, Toda K, Horio T. Ultraviolet-B radiation suppresses mast cell degranulation induced by compound 48/80. J Invest Dermatol 1986;87:775-8, doi:10.1111/1523-1747.ep12458843.
48. Toda K, Danno K, Tachibana T, Horio T. Effect of 8-methoxypsoralen plus long-wave ultraviolet (PUVA) radiation on mast cells. II. In vitro PUVA inhibits degranulation of rat peritoneal mast cells induced by compound 48/80. J Invest Dermatol 1986;87:113-6, doi:10.1111/1523-1747.ep12523611.
49. Horio T. Indications and action mechanisms of phototherapy. J Dermatol Sci 2000;23 Suppl 1:S17-21, doi:10.1016/S0923-1811 (99)00069-9.
50. Miyauchi H, Horio T. Ultraviolet B-induced local immunosuppression of contact hypersensitivity is modulated by ultraviolet irradiation and hapten application. J Invest Dermatol 1995;104: 364-9, doi:10.1111/1523-1747. ep12665832.
51. Beissert S, Mohammad T, Torri H, et al. Regulation of tumor antigen presentation by urocanic acid. J Immunol 1997;159:92-6.
52. Gibbs NK, Norval M, Traynor NJ, et al. Comparative potency of broad-band and narrow-band phototherapy sources to induce edema, sunburn cells and urocanic acid photoisomerization in hairless mouse skin. Photochem Photobiol 1993;58:643-7, doi: 10.1111/j.1751-1097.1993.tb04946.x.
53. Gilmour JW, Vestey JP, Norval M. The effect of UV therapy on immune function in patients with psoriasis. Br J Dermatol 1993; 129:28-38, doi:10.1111/j.1365-2133.1993.tb03307.x.
54. Guckian M, Jones CD, Vestey JP, et al. Immunomodulation at the initiation of phototherapy and photochemotherapy. Photodermatol Photoimmunol Photomed 1995;11:163-9, doi:10.1111/j.1600-0781. 1995.tb00160.x.
55. Abou EL-Ela M, Nagui N, Mahgoub D, et al. Expression of cyclin D1 and p16 in psoriasis before and after phototherapy. Clin Exp Dermatol 2010;35:781-5, doi:10.1111/j.1365-2230.2009.03774.x.
56. Miyakawa Y, Matsushime H. Rapid downregulation of cyclin D1 mRNA and protein levels by ultraviolet irradiation in murine macrophage cells. Biochem Biophys Res Commun 2001;284:71-6, doi:10.1006/bbrc.2001.4950.
57. Kim AL, Athar M, Bickers DR, Gautier J. Ultraviolet-B-induced G1 arrest is mediated by downregulation of cyclin-dependent kinase 4 in transformed keratinocytes lacking functional p53. J Invest Dermatol 2002;118:818-24, doi:10.1046/j.1523-1747. 2002.01734.x.
58. Rácz E, Prens EP, Kant M, et al. Narrowband ultraviolet B inhibits innate cytosolic double-stranded RNA receptors in psoriatic skin and keratinocytes. Br J Dermatol 2011;164:838-47, doi:10.1111/j.1365-2133.2010. 10169.x.
59. Hochberg M, Zeligson S, Amariglio N, et al. Genomic-scale analysis of psoriatic skin reveals differentially expressed insulin-like growth factor-binding protein-7 after phototherapy. Br J Dermatol 2007;156:289-300, doi:10.1111/j.1365-2133.2006.07628.x.